Mads Krogsgaard Thomsen
Executive vice president
Executive Management
Novo Nordisk
Denmark
Biography
Mads Krogsgaard Thomsen joined Novo Nordisk in 1991 as head of Growth Hormone Research. Following that he directed Diabetes R&D and Global Drug Discovery, and in November 2000 he was appointed executive vice president and chief science officer. In this role, he is responsible for global drug and device research, development, medical affairs, regulatory and safety within Novo Nordisk. Professor Thomsen has chaired Danish Research Council programmes within endocrinology, and has served as president of the National Academy of Technical Sciences (ATV), Denmark. Today, he serves as chairman of the board of the University of Copenhagen, Denmark. He is also a member of the editorial boards of international, peer-reviewed journals.
Research Interest
Health and Medical Sciences
